Useful resources |
Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer (Cochrane Review) ABSTRACT Background: Intravesical therapy with Bacillus Calmette-Guerin (BCG) aims to reduce the incidence of tumour recurrence following transurethral resection (TUR) for patients with superficial bladder cancer. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |